INSIDE THE JOURNALS: ACG CLINICAL GUIDELINE
MANAGEMENT OF DYSPEPSIA Paul Moayyedi, MB ChB, PhD, MPH, FACG; Brian E. Lacy, MD, PhD, FACG; Christopher N. Andrews, MD; Robert A. Enns, MD; Colin W. Howden, MD, FACG; and Nimish Vakil, MD, FACG.
IN THE FIRST UPDATE IN MORE THAN 10 YEARS, the American College of Gastroenterology and the Canadian Association of Gastroenterology joined forces on an updated systematic review and clinical guideline on dyspepsia management. The focus of the guideline is on initial investigations for dyspepsia, such as Helicobacter pylori testing and endoscopy, as well as pharmacological therapies such as H. pylori treatment, PPIs and prokinetic therapy. The authors do not address the management of organic pathology that may present with dyspepsia identified at endoscopy, such as esophagitis or peptic ulcer disease, as there are other ACG guidelines for these specific diseases. Further, when H. pylori testing or treatment is recommended, we do not specify which investigation or which therapy to use, as this will be addressed in an ACG Guideline on H. pylori and other recent guidelines that have been published.
Listen to the AJG Podcast Paul Moayyedi, MB ChB, PhD, MPH, FACG, discusses the evolving definition and diagnosis of dyspepsia, when and when not to use endoscopy, and how H. pylori factors into dyspepsia treatment in a conversation with AJG Co-Editorin-Chief, Brennan M.R. Spiegel MD, MSHS, FACG. LISTEN Here: goo.gl/9gd835
42 | GI.ORG/ACGMAGAZINE
Figure 1. Algorithm for the management of undiagnosed dyspepsia.
Figure 2. Algorithm for the treatment of functional dyspepsia.
